NTME — Netmed Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.29m
1997 December 31st | 1998 December 31st | 1999 December 31st | 2000 December 31st | 2001 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K405 | 10-K | 10KSB | 10KSB | 10KSB40 |
Standards: | — | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.894 | 0.4 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.35 | 1.97 | 1.04 | 0.58 | 0.431 |
Operating Profit | -2.45 | -1.57 | -1.04 | -0.58 | -0.431 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.8 | -2.65 | -0.578 | 0.846 | -0.317 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.28 | -2.65 | -0.578 | 0.812 | -0.314 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3.28 | -2.64 | -0.595 | 0.801 | -0.339 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -3.28 | -2.64 | 0.186 | 0.738 | -0.339 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.3 | -0.152 | 0.019 | 0.029 | -0.031 |
Dividends per Share |